Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An intestinal TH17 cell-derived subset can initiate cancer

Autor: Fesneau, Olivier, Thevin, Valentin, Pinet, Valérie, Goldsmith, Chloe, Vieille, Baptiste, M’Homa Soudja, Saïdi, Lattanzio, Rossano, Hahne, Michael, Dardalhon, Valérie, Hernandez-Vargas, Hector, Benech, Nicolas, Marie, Julien C.

Publikováno v: Nature Immunology; 20240101, Issue: Preprints p1-13, 13p

Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota.

Autor: Akagbosu, Blossom, Tayyebi, Zakieh, Shibu, Gayathri, Paucar Iza, Yoselin A., Deep, Deeksha, Parisotto, Yollanda Franco, Fisher, Logan, Pasolli, H. Amalia, Thevin, Valentin, Elmentaite, Rasa, Knott, Maximilian, Hemmers, Saskia, Jahn, Lorenz, Friedrich, Christin, Verter, Jacob, Wang, Zhong-Min, van den Brink, Marcel, Gasteiger, Georg, Grünewald, Thomas G. P., Marie, Julien C.

Publikováno v: Nature; Oct2022, Vol. 610 Issue 7933, p752-760, 9p

Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota

Autor: Akagbosu, Blossom, Tayyebi, Zakieh, Shibu, Gayathri, Paucar Iza, Yoselin A., Deep, Deeksha, Parisotto, Yollanda Franco, Fisher, Logan, Pasolli, H. Amalia, Thevin, Valentin, Elmentaite, Rasa, Knott, Maximilian, Hemmers, Saskia, Jahn, Lorenz, Friedrich, Christin, Verter, Jacob, Wang, Zhong-Min, van den Brink, Marcel, Gasteiger, Georg, Grünewald, Thomas G. P., Marie, Julien C., Leslie, Christina, Rudensky, Alexander Y., Brown, Chrysothemis C.

Publikováno v: Nature; 20220101, Issue: Preprints p1-9, 9p

An intestinal T H 17 cell-derived subset can initiate cancer.

Autor: Fesneau O; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., Thevin V; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., Pinet V; Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France., Goldsmith C; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., Vieille B; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., M'Homa Soudja S; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., Lattanzio R; Department of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy., Hahne M; Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France., Dardalhon V; Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France., Hernandez-Vargas H; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France., Benech N; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France.; Hospices Civils de Lyon, Service d'Hépato-Gastroentérologie, Croix Rousse Hospital, Lyon, France., Marie JC; Cancer Research Center of Lyon (CRCL) INSERM U 1052, CNRS UMR 5286, Centre Léon Bérard, Claude Bernard Lyon 1 University, Lyon, France. julien.marie@inserm.fr.; Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France. julien.marie@inserm.fr.

Publikováno v: Nature immunology [Nat Immunol] 2024 Sep; Vol. 25 (9), pp. 1637-1649. Date of Electronic Publication: 2024 Jul 26.